Asset
DEXISOMETHEPTENE MUCATE
Tonix Pharmaceuticals Holding Corp. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02290379 | phase1 | completed | 2014-11-01 | 2015-05-01 | Tonix Pharmaceuticals, Inc. | Phase 1 Single Ascending Dose Safety Study of TNX-201 Capsules in Healthy Volunteers |
| NCT02423408 | phase2 | completed | 2015-06-01 | 2016-02-01 | Tonix Pharmaceuticals, Inc. | Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache |
FDA applications (0)
This company has no applications containing this asset.